TEVA PHARMACEUTICAL INDUSTRIES financial statements, including revenue, expenses, profit, and loss

The total revenue of TEVA/N for the last quarter is 76.34 B MXN, and it's 20.21% higher compared to the previous quarter. The net income of Q2 24 is -15.50 B MXN.